Subject(s)
Humans , Male , Female , Angioedemas, Hereditary/immunology , Complement C1 Inhibitor Protein , Sterol Esterase , Hereditary Angioedema Types I and II/epidemiology , Hereditary Angioedema Types I and II/prevention & control , Hereditary Angioedema Types I and II/physiopathology , Hereditary Angioedema Types I and II/diagnosis , Hereditary Angioedema Types I and II/immunology , Complement C1 Inhibitor Protein/immunology , Complement C1 Inhibitor Protein/isolation & purification , Latin America/epidemiologyABSTRACT
Early diagnosis and appropriate therapy are essential for the best prognosis and quality of life in patients with primary immunodeficiency diseases (PIDDs). Experts from several Latin American countries have been meeting on a regular basis as part of an on going effort to improve the diagnosis and treatment of PIDD in this region. Three programmes are in development that will expand education and training and improve access to testing facilities through out Latin America. These programmes are: an educational out reach programme (The L-Project); an immunology fellowship programme; and the establishment of a laboratory network to expand access to testing facilities. This report provides the status of these programmes based on the most recent discussions and describes the next steps toward full implementation of these programmes (AU)
